Publication | Open Access

Discovery and optimization of a new class of pyruvate kinase inhibitors as potential therapeutics for the treatment of methicillin-resistant Staphylococcus aureus infections

Antimicrobial SusceptibilityBiochemistryPotential TherapeuticsMedicineAntibiotic AdjuvantNew ClassPyruvate Kinase InhibitorsAntimicrobial ChemotherapyAntimicrobial CompoundPharmacologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance